摘要
由L8（27）表按排治疗3月龄以下伴有憋气的百日咳及百日咳综合征80例。观察憋气Apgar评分减轻1度的天数和憋气消失无数，以比较应用地塞米松、息斯敏、20％人体白蛋白和维生素K1用与不用对上述两者的影响。经方差分析结果，前者依次为P＜0．01;P＞0.05；P＜0.05和P＞0．05；后者依次为P＜0．01；P＞0．05；P＞0．05和P＞0．05。极差分析，前者地塞米松为1.1625天、20％人体白蛋白为0.8125天，后者地塞米松为1．175天。结果提示，地塞米松能较快地减轻憋气的严重程度，并能缩短憋气的发作天数；20％人体白蛋白也能减轻憋气的严重程度，但作用比地塞米松差。
Dexamethasonum, astessizole 20% human albumin and vitamine K1 wereused to treat the suffocation (sneeze crisis) of pertussis and pertussal syndrome in 80 infants, aged 28-100 day, according as L8 (27) table. The days in which the suffocation wasdecreased one degree or Apgar evaluation and disappeared were used as criteria. The curativeeffects ranged from dexamethasonum, 20% albumin, astemizole to vitaminum K1; by analysis of variane and analysis of range. Dexamethasonum can rapidly decrease the severity ofsuffocation and shorten the duration of the attacks. This data suggest that the most effectivetherapy of suffocation is decreasing respiratory duct congestion and edema.
出处
《急诊医学》
CSCD
1995年第2期103-106,共4页
关键词
百日咳综合征
憋气
地塞米松
治疗
儿童
pertussis pertussal syndrome suffocation dexamethasonum human albumin astemizole vitamine K_1
